2026. Network pharmacology and molecular docking identify eugenol as a lead compound targeting visceral leishmaniasis pathways with nanotechnology-driven drug design and nanoscale interaction analysis. Experimental and Theoretical NANOTECHNOLOGY. 10, 3 (Jul. 2026), 1449–1468. DOI:https://doi.org/10.56053/10.3.1449.